Search
for
Sort by
Research 541–570 of 893
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Drug-induced scarring and permanent alopecia
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Autoinmune Alopecia/Alopecia Areata
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- Hair Transplantation
- From the Elephant Man to Barbie Girl: Dissecting the Freak from the Margins to the Mainstream
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Treatment of pediatric alopecia areata: A systematic review
- Alopecia and Associated Toxic Agents: A Systematic Review
- Scalp cooling to prevent chemotherapy-induced alopecia
- Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Genetic interplays between Msx2 and Foxn1 are required for Notch1 expression and hair shaft differentiation
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Expanding phenotype of hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis caused by FAM111B mutations: Report of an additional family raising the question of cancer predisposition and a short review of early-onset poikiloderma
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Management of Dermatologic Toxicities
- Clinical Presentations and Comorbidities of Pediatric Alopecia Areata